Share Buyback Programme

Spire Healthcare Group plc (LSE: SPI) ("Spire Healthcare" or "Company"), a leading independent healthcare group in the United Kingdom, announces a return of up to £5m cash to its shareholders through the means of an on-market share buyback programme (the "Programme").

Spire Healthcare has entered into a non-discretionary arrangement with Numis Securities Limited, trading as Deutsche Numis, to conduct the Programme on its behalf commencing today, 31 October 2024, and ending no later than 31 December 2024. Under these arrangements, Deutsche Numis will conduct the repurchases of the Company's ordinary shares of 1 pence each (the "Ordinary Shares") up to a maximum aggregate consideration of £5m and will make trading decisions in relation to the buyback of the Ordinary Shares within the programme terms and pre-set parameters.

The sole purpose of the Programme is to reduce the issued share capital of the Company, delivering further value for shareholders, and any Ordinary Shares purchased under the Programme will be cancelled.

The Programme will be conducted by the Company in accordance with and under the terms of the general authority granted by the Company's shareholders at the Company's Annual General Meeting on 9 May 2024, pursuant to which the Company has authority to purchase a maximum of 40,413,223 Ordinary Shares (subject to certain limitations) (the "General Authority"). The aggregate number of Ordinary Shares which may be acquired by the Company pursuant to the Programme will not exceed the maximum number of Ordinary Shares which the Company is authorised to purchase pursuant to the General Authority.

Any purchase of Ordinary Shares made in relation to the Programme will be carried out on the London Stock Exchange. The buyback by Spire Healthcare will be executed in accordance with Chapter 9 of the UK Listing Rules and the terms of the General Authority. The Programme will be conducted within the parameters prescribed by the Market Abuse Regulation (EU) 596/2014, the Commission Delegated Regulation (EU) 2016/1052 (both as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and with regard to regulatory technical standards for the conditions applicable to buy-back programmes and stabilisation measures.

Spire Healthcare will announce any purchase by it of Ordinary Shares no later than 7.30 a.m. on the business day following the calendar day on which the purchase occurs.

The Company will make further announcements in due course following the completion of any repurchases. There is no guarantee that the Programme will be implemented in full or that any Ordinary Shares will be repurchased by the Company.

The Company confirms that it currently has no unpublished price sensitive information.

​